{"SPADE_UN_16322": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16322", "Peptide Name": "ChBac3.4 (1-14)-NH2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RFRLPFRRPPIRIH", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/P85170"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:K562 (IC50=33.6 ± 4.1 μM); U-937 (IC50>64 μM)", "Hemolytic Activity": "Human erythrocytes:<5% Hemolysis=64 µM", "Cytotoxicity": "Human PBMC:IC50>64 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C87H141N31O15", "Mass": 1861.25, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.86, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs", "Pubmed ID": "33194795", "Reference": "Front Cell Infect Microbiol. 2020 Oct 19;10552905.", "Author": "Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33194795"}], "Frequent Amino Acids": "RPF", "Absent Amino Acids": "ACDEGKMNOQSTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03222", "Similarity": 1.0, "Sequence": "RFRLPFRRPPIRIHPPPFYPPFRRFL"}, {"SPADE_ID": "SPADE_N_13216", "Similarity": 1.0, "Sequence": "AARIILRFRFR"}, {"SPADE_ID": "SPADE_N_15327", "Similarity": 1.0, "Sequence": "RFRLPFRRPPIRIHPPPFYPPFRRFLGRR"}]}}}